MPM BioVentures 2018 LLC, 10% Owner at iTeos Therapeutics, Inc. (ITOS), sold 166,142 shares at $34.62 ($5.7M) on 2021-11-30, disclosed to the SEC on 2021-12-02.
Scheduled sale ($5.7M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.62 | 5,861 | $203K | 3.5% |
| 2 | $34.62 | 5,861 | $203K | 3.5% |
| 3 | $35.19 | 28,076 | $988K | 17.3% |
| 4 | $35.19 | 28,076 | $988K | 17.3% |
| 5 | $33.82 | 6,042 | $204K | 3.6% |
| 6 | $33.82 | 6,042 |
| $204K |
| 3.6% |
| 7 | $34.61 | 5,457 | $189K | 3.3% |
| 8 | $34.61 | 5,457 | $189K | 3.3% |
| 9 | $35.34 | 896 | $32K | 0.6% |
| 10 | $33.74 | 29,757 | $1.0M | 17.5% |
| 11 | $33.74 | 29,757 | $1.0M | 17.5% |
| 12 | $34.83 | 7,430 | $259K | 4.5% |
| 13 | $34.83 | 7,430 | $259K | 4.5% |
| Total | $34.46 avg | 166,142 | $5.7M | 100% |
| Filing → |